N. Ogawa

474 total citations
25 papers, 381 citations indexed

About

N. Ogawa is a scholar working on Molecular Biology, Biotechnology and Biochemistry. According to data from OpenAlex, N. Ogawa has authored 25 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Biotechnology and 5 papers in Biochemistry. Recurrent topics in N. Ogawa's work include Phytochemicals and Antioxidant Activities (5 papers), Cancer Research and Treatments (4 papers) and Plant biochemistry and biosynthesis (4 papers). N. Ogawa is often cited by papers focused on Phytochemicals and Antioxidant Activities (5 papers), Cancer Research and Treatments (4 papers) and Plant biochemistry and biosynthesis (4 papers). N. Ogawa collaborates with scholars based in Japan, United States and Australia. N. Ogawa's co-authors include Tsutomu Hatano, Takuo Okuda, Taeko Yasuhara, Reiko Kira, Kazufumi Yazaki, Kenichi Hashizume, Tetsuro Shingu, Jian Liang, Junichi Tanaka and Tatsuo Higa and has published in prestigious journals such as Tetrahedron, International Journal of Multiphase Flow and Chemical and Pharmaceutical Bulletin.

In The Last Decade

N. Ogawa

23 papers receiving 356 citations

Peers

N. Ogawa
Comparison fields: 5 of 75
  • Molecular Biology 169
  • Biochemistry 108
  • Plant Science 70
  • Organic Chemistry 65
  • Pharmacology 37
Replace Yasumoto Mizoguchi with:
Yasumoto Mizoguchi Japan
Hiroshi Higashihara Japan
Kouichi Saeki Japan
Yoshitaka Hitomi Japan
D. Arul India
Hyo Kon Chun South Korea
Maaike E. Schutte Netherlands
Jong Moon Hur South Korea
Renato Heidor Brazil
Saet Byoul Lee South Korea
Yasumoto Mizoguchi Japan View profile →
Citations per field, relative to N. Ogawa
N. Ogawa · 1×
Citations per year, relative to N. Ogawa
N. Ogawa · 1×

Countries citing papers authored by N. Ogawa

Since Specialization
Citations

This map shows the geographic impact of N. Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Ogawa more than expected).

Fields of papers citing papers by N. Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Ogawa. The network helps show where N. Ogawa may publish in the future.

Co-authorship network of co-authors of N. Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of N. Ogawa. A scholar is included among the top collaborators of N. Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Ogawa. N. Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Using gaussian curvature for the 3D segmentation of snow grains from microtomographic data
4
2 2
3
[Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin].
1
4
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer].
2
5 1
6 16
7 5
8
Employment Adjustment in Japan
1
9
[Comparative clinical study in metastatic liver cancer between intra-arterial infusion of mitomycin C alone and intra-arterial infusion of mitomycin C combined with PJ-203 (degradable starch microspheres)].
4
10
[Multi-center cooperative phase II study of combined infusion of PJ-203 (degradable starch microspheres) into hepatic artery in metastatic liver cancer].
4
11
[Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen].
15
12
The use of degradable starch microspheres (Spherex) with intra-arterial chemotherapy for the treatment of primary and secondary liver tumours - Results of a phase III clinical trial
25
13 4
14 33
15 95
16 18
17 22
18 25
19 40
20 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026